Literature DB >> 8971719

Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway.

T L Yahr1, J Goranson, D W Frank.   

Abstract

Exoenzyme S is an extracellular ADP-ribosyltransferase of Pseudomonas aeruginosa. Transposon mutagenesis of P. aeruginosa 388 was used to identify genes required for exoenzyme S production. Five Tn5Tc insertion mutants were isolated which exhibited an exoenzyme S-deficient phenotype (388::Tn5Tc 469, 550, 3453, 4885, and 5590). Mapping experiments demonstrated that 388::Tn5Tc 3453, 4885, and 5590 possessed insertions within a 5.0 kb EcoRI fragment that is not contiguous with the exoenzyme S trans-regulatory operon. 388::Tn5Tc 469 and 550 mapped to a region downstream of the trans-regulatory operon which has been previously shown to contain a promoter region that is co-ordinately regulated with exoenzyme S synthesis. Nucleotide sequence analysis of a 7.2 kb region flanking the 388::Tn5Tc 469 and 550 insertions, identified 12 contiguous open reading frames (ORFs). Database searches indicated that the first ORF, ExsD, is unique. The other 11 ORFs demonstrated high homology to the YscB-L proteins of the yersiniae Yop type III export apparatus. RNase-protection analysis of wild-type and mutant strains indicated that exsD and pscB-L form an operon. To determine whether ExoS was exported by a type III mechanism, derivatives consisting of internal deletions or lacking amino- or carboxy-terminal residues were expressed in P. aeruginosa. Deletion analyses indicated that the amino-terminal nine residues are required for ExoS export. Combined data from mutagenesis, regulatory, expression, and sequence analyses provide strong evidence that P. aeruginosa possesses a type III secretion apparatus which is required for the export of exoenzyme S and potentially other co-ordinately regulated proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971719     DOI: 10.1046/j.1365-2958.1996.01554.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  115 in total

1.  Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.

Authors:  E M McGuffie; J E Fraylick; D J Hazen-Martin; T S Vincent; J C Olson
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.

Authors:  M L Henriksson; R Rosqvist; M Telepnev; H Wolf-Watz; B Hallberg
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

3.  Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.

Authors:  D Dacheux; I Attree; B Toussaint
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.

Authors:  A J Vallis; V Finck-Barbançon; T L Yahr; D W Frank
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Characterization of Pseudomonas aeruginosa chitinase, a gradually secreted protein.

Authors:  J Folders; J Algra; M S Roelofs; L C van Loon; J Tommassen; W Bitter
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

6.  PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.

Authors:  I A Holder; A N Neely; D W Frank
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Strain-dependent induction of neutrophil histamine production and cell death by Pseudomonas aeruginosa.

Authors:  Xiang Xu; Hong Zhang; Yuanlin Song; Susan V Lynch; Clifford A Lowell; Jeanine P Wiener-Kronish; George H Caughey
Journal:  J Leukoc Biol       Date:  2011-11-10       Impact factor: 4.962

8.  Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon.

Authors:  Denis Dacheux; Olivier Epaulard; Arjan de Groot; Benoit Guery; Rozen Leberre; Ina Attree; Benoit Polack; Bertrand Toussaint
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 10.  The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.

Authors:  G R Cornelis
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.